We demonstrated the association of plasma GFAP, NfL, p‐tau181, and Aβ42/40 with performance on several cognitive domains at baseline, domain‐specific cognitive decline over time, and functional independence in ADLs across neurodegenerative and cerebrovascular diseases in the clinical, multi‐site ONDRI cohort. Here, GFAP is linked to cerebrovascular disorder.